It beat smallpox. So now what else can it do?

Genetically altered, the anti-smallpox virus vaccinia can fight many other diseases, writes Bernard Dixon

Is smallpox vaccine due for a comeback? It may seem perverse to ask such a question in 1996. This is the 200th anniversary of Edward Jenner's successful vaccination of young James Phipps, which led to the widespread adoption of Jenner's method of preventing smallpox by infecting people with the related cowpox virus (vaccinia). Two centuries later, having eradicated smallpox using Jenner's technique, the World Health Organisation has announced that the two remaining laboratory stocks of the virus are to be destroyed.

With smallpox gone, there might seem to be little further use for vaccinia. But many other viruses continue to cause disease and death on a vast scale throughout the world. And one means of combating them may be to use genetically altered forms of vaccinia.

One expert who believes so is Enzo Paoletti. More than 10 years ago he discovered how to insert genes from other microbes into the DNA of vaccinia. In principle, if such an inserted gene normally produces a particular protein in the donor microbe, then it could do so in the cells of its new host too. And if that protein, in its original place, induced an infected animal to produce antibodies, the augmented vaccinia virus might do the same thing.

It worked. Scientists have since engineered several such "recombinant vaccines". One is a version of vaccinia designed to provoke immunity against rabies when taken by mouth. It has been distributed in several parts of Western Europe, injected into chicken heads left to be eaten by wild foxes, which can carry rabies. Many foxes took the bait and the disease is virtually extinct in Belgium.

Although such vaccines appear to be safe, scientists remain cautious about the prospects of using similar ones in humans, or in animals in contact with humans. First, the procedure is not trouble-free. At the injection site, vaccinia can cause unpleasant reactions, which are likely to be severe in individuals whose immune systems are impaired - by Aids, for example, or by drugs given to prevent the rejection of transplanted organs. Second, it is theoretically possible that a genetically altered vaccinia virus could pass from humans to wildlife, or interact with related viruses, with uncertain consequences.

Paoletti believes that an alternative approach may prove more acceptable and equally effective: to use viruses that have the advantages of the first generation of recombinant vaccines, but none of their disadvantages. Several are being developed which have virtually no side-effects, provoke immunity and, like conventional vaccinia, are "live"; they do not reproduce (or do so poorly) in recipients' cells and so cannot spread to other animals.

As a basis for one range of vaccines, Paoletti and colleagues have removed several regions of DNA from vaccinia that it require to multiply harmfully. Known as NYVAC, the resulting virus retains the capacity to grow normally in chick embryo cells, yet can scarcely grow at all in human and other animal cells. NYVAC does not produce inflammation at the injection site, and has negligible ill-effects, even in mice whose immune systems have been compromised. When researchers incorporated into NYVAC relevant genes taken from Japanese encephalitis virus and equine influenza virus, the resulting vaccines protected pigs and horses respectively against these infections.

Another strategy, pioneered by the Virogenetics Corporation, focuses on vaccinia-related viruses that normally infect birds. These too can be genetically altered so that they immunise various mammals against other microbes, even though the viruses do not multiply in mammalian cells. A modified canarypox virus, for example, has protected dogs and cats experimentally against rabies.

A recently recognised use for recombinant poxviruses is in cancer treatment. Many types of tumour cell have on their surface antigens - proteins characteristic of those tumours - which can induce the body to make antibodies. Unfortunately, the response of the immune system to such antigens is normally weak or non-existent. However, a poxvirus carrying not only a tumour antigen but also a cytokine (a natural substance that heightens the immune response) might provoke the production of sufficient antibody to attack a patient's tumour.

Start your day with The Independent, sign up for daily news emails
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Guru Careers: .NET Developer / Web Developer

£35-45K (DOE) + Benefits: Guru Careers: We are seeking a .NET Developer / Web ...

Recruitment Genius: Full Time and Part Time Digital Designer - North Kent

£20000 - £23000 per annum: Recruitment Genius: This successful web design/deve...

SThree: Trainee Recruitment Consultant

£18000 - £25000 per annum + Commission: SThree: Are you great at building rela...

SThree: Trainee Recruitment Consultant - Dublin (based in London)

£20000 - £25000 per annum + commission: SThree: Real Staffing's Pharmaceutical...

Day In a Page

Revealed: Why Mohammed Emwazi chose the 'safe option' of fighting for Isis, rather than following his friends to al-Shabaab in Somalia

Why Mohammed Emwazi chose Isis

His friends were betrayed and killed by al-Shabaab
'The solution can never be to impassively watch on while desperate people drown'
An open letter to David Cameron: Building fortress Europe has had deadly results

Open letter to David Cameron

Building the walls of fortress Europe has had deadly results
Tory candidates' tweets not as 'spontaneous' as they seem - you don't say!

You don't say!

Tory candidates' election tweets not as 'spontaneous' as they appear
Mubi: Netflix for people who want to stop just watching trash

So what is Mubi?

Netflix for people who want to stop just watching trash all the time
The impossible job: how to follow Kevin Spacey?

The hardest job in theatre?

How to follow Kevin Spacey
Armenian genocide: To continue to deny the truth of this mass human cruelty is close to a criminal lie

Armenian genocide and the 'good Turks'

To continue to deny the truth of this mass human cruelty is close to a criminal lie
Lou Reed: The truth about the singer's upbringing beyond the biographers' and memoirists' myths

'Lou needed care, but what he got was ECT'

The truth about the singer's upbringing beyond
Migrant boat disaster: This human tragedy has been brewing for four years and EU states can't say they were not warned

This human tragedy has been brewing for years

EU states can't say they were not warned
Women's sportswear: From tackling a marathon to a jog in the park, the right kit can help

Women's sportswear

From tackling a marathon to a jog in the park, the right kit can help
Hillary Clinton's outfits will be as important as her policies in her presidential bid

Clinton's clothes

Like it or not, her outfits will be as important as her policies
NHS struggling to monitor the safety and efficacy of its services outsourced to private providers

Who's monitoring the outsourced NHS services?

A report finds that private firms are not being properly assessed for their quality of care
Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

The Tory MP said he did not want to stand again unless his party's manifesto ruled out a third runway. But he's doing so. Watch this space
How do Greek voters feel about Syriza's backtracking on its anti-austerity pledge?

How do Greeks feel about Syriza?

Five voters from different backgrounds tell us what they expect from Syriza's charismatic leader Alexis Tsipras
From Iraq to Libya and Syria: The wars that come back to haunt us

The wars that come back to haunt us

David Cameron should not escape blame for his role in conflicts that are still raging, argues Patrick Cockburn
Sam Baker and Lauren Laverne: Too busy to surf? Head to The Pool

Too busy to surf? Head to The Pool

A new website is trying to declutter the internet to help busy women. Holly Williams meets the founders